You cannot hide the truth forever

[Okiya]

A new french study showed 91% efficacy rate of hydroxycloroquine. President Macron went to visit the doctor yesterday.

Very soon the lame stream media are going to go wild telling everyone that Orange man has interest in Sanofi, a company that makes hydroxycloroquine. But they will conveniently fail to say that the interest is almost negligible.

 

[Mwendawazimu]

Politics aside,we need a cure fast.

 

[Burner]

A new french study showed 91% efficacy rate of hydroxycloroquine. President Macron went to visit the doctor yesterday.

Very soon the lame stream media are going to go wild telling everyone that Orange man has interest in Sanofi, a company that makes hydroxycloroquine. But they will conveniently fail to say that the interest is almost negligible.



View attachment 9213View attachment 9214

The doctor's study has come under some criticism from peer review groups. This is why noone is harping about it being a magical bullet against covid other than trump.
I don't even pretend to understand the criticism laid out, so maybe @Luther12 can tell us if these are valid concerns.

Criticisms are here:

Thoughts on the Gautret et al. paper about Hydroxychloroquine and Azithromycin treatment of COVID-19 infections

There has been a lot of excitement – and even a presidential tweet about a recent paper from the lab of Didier Raoult, an infectious disease specialist in Marseille, France. But although this…

scienceintegritydigest.com

Hydroxychloroquine-COVID-19 study did not meet publishing society’s “expected standard”

Didier Raoult The paper that appears to have triggered the Trump administration’s obsession with hydroxychloroquine as a treatment for infection with the novel coronavirus has received a statement …

retractionwatch.com

PubPeer - Hydroxychloroquine and azithromycin as a treatment of COVID-...

There are comments on PubPeer for publication: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial (2020)

pubpeer.com

 

[Okiya]

The doctor's study has come under some criticism from peer review groups. This is why noone is harping about it being a magical bullet against covid other than trump.
I don't even pretend to understand the criticism laid out, so maybe @Luther12 can tell us if these are valid concerns.

Criticisms are here:

Thoughts on the Gautret et al. paper about Hydroxychloroquine and Azithromycin treatment of COVID-19 infections

There has been a lot of excitement – and even a presidential tweet about a recent paper from the lab of Didier Raoult, an infectious disease specialist in Marseille, France. But although this…

scienceintegritydigest.com

Hydroxychloroquine-COVID-19 study did not meet publishing society’s “expected standard”

Didier Raoult The paper that appears to have triggered the Trump administration’s obsession with hydroxychloroquine as a treatment for infection with the novel coronavirus has received a statement …

retractionwatch.com

PubPeer - Hydroxychloroquine and azithromycin as a treatment of COVID-...

There are comments on PubPeer for publication: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial (2020)

pubpeer.com

The criticism youve shared were on the first set of patients. What I've posted is findings of a new study.

 

[Anglututu]

A big hand for Dr Trump and his campaign manager @Okiya

 

[kijanamrefu]

The doctor's study has come under some criticism from peer review groups. This is why noone is harping about it being a magical bullet against covid other than trump.
I don't even pretend to understand the criticism laid out, so maybe @Luther12 can tell us if these are valid concerns.

Criticisms are here:

Thoughts on the Gautret et al. paper about Hydroxychloroquine and Azithromycin treatment of COVID-19 infections

There has been a lot of excitement – and even a presidential tweet about a recent paper from the lab of Didier Raoult, an infectious disease specialist in Marseille, France. But although this…

scienceintegritydigest.com

Hydroxychloroquine-COVID-19 study did not meet publishing society’s “expected standard”

Didier Raoult The paper that appears to have triggered the Trump administration’s obsession with hydroxychloroquine as a treatment for infection with the novel coronavirus has received a statement …

retractionwatch.com

PubPeer - Hydroxychloroquine and azithromycin as a treatment of COVID-...

There are comments on PubPeer for publication: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial (2020)

pubpeer.com

@Okiya has shared a new study, not the older one on less than 50 patients.

Edit: I see he's clarified above.

 

[emali]

lets hope this hippy doctor is right